Hypoglycemic and insulin mimetic impact of catechin isolated from Cassia fistula: A substantiate in silico approach through docking analysis

Medicinal Chemistry Research

Volumn 21, Issue 9, 2012, Pages 2238-2250

  Pitchai, Daisy ^a   Manikkam, Rajalakshmi ^a  

^a HOLY CROSS COLLEGE   (India)

Author keywords

Cassia fistula; Catechin; Insulin receptor and hypoglycemic; Ligand based drug design; PPAR

Indexed keywords

CATECHIN; INSULIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BINDING SITE; CASSIA FISTULA; COMPUTER MODEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; MALE; MOLECULAR DOCKING; NONHUMAN; RAT; STRUCTURE ANALYSIS;

EID: 84866383091     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9722-1     Document Type: Article

References (45)

1. Alarcon-Aguilara FJ, Jimenez-Estrada M, Reyes-Chilpa R, Roman-Ramos R (2000) Hypoglycemic effect of extracts and fractions from Psacalium decompositum in healthy and alloxan diabetic mice. J Ethnopharmacol 72:21-27
2. Amalraj T, Ignacimuthu S (1998) Evaluation of the hypoglycemic effect of Memecylon umbellatum in normal and alloxan diabetic mice. J Ethnopharmacol 62:247-250 (Pubitemid 28493377)
3. Anuradha K, Hota D, Pandhi P (2004) Investigation of Central mechanism of Insulin induced hypoglycemic convulsions in mice. Indian J Exp Biol 42:368-372 (Pubitemid 38449058)
4. Becker OM, Dhanoa DS, Marantz Y, Chen D, Shacham S (2006) An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression. J Med Chem 49:3116-3135 (Pubitemid 43830511)
5. Bellacossa A, Testa JR, Staal SP, Tsichlis PN (1991) A retero viral oncogene akt encoding a serinethreonine kinase containing an SH2-like region. Science 254:244-247
6. Bonkovsky HL, Azar R, Bird S, Szabo G, Banner B (2002) Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone. Dig Dis Sci 47(7):1632-1637 (Pubitemid 34753947)
7. Boon NA, Colledge NR, Walker BR (2006) Davidson's principles and practice of medicine: diabetes mellitus, 20th edn. Elsevier, London, pp 805-847
8. Brooijmans N, Kuntz ID (2003) Molecular recognition and docking algorithms. Annu Rev Biophys Biomol Struct 32:335-373 (Pubitemid 37056233)
9. Burke JP, Williams K, Narayan KM, Leibson C, Haffner SM, Stern MP (2003) A population perspective on diabetes prevention: whom should we target for preventing weight gain? Diabetes Care 26:1999-2004 (Pubitemid 41184241)
10. Chatwal GR (1999) Medicinal chemistry. Himalaya Publishing House, Connemara
11. Cheng A, Merz K Jr (2003) Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships. J Med Chem 46:3572-3580 (Pubitemid 36988646)
12. Daisy P, Balasubramanian K, Rajalakshmi M, Eliza J, Selvaraj J (2010) Insulin mimetic impact of Catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on Streptozotocin-induced diabetic Wistar rats. Phytomedicine 17:28-36
13. Dixon SL, Merz KMM Jr (2001) One-dimensional molecular representations and similarity calculations: methodology and validation. J Med Chem 44:3795-3809 (Pubitemid 33051472)
14. Dixon SL, Villar HO (1999) Investigation of classification methods for the prediction of activity in diverse chemical libraries. J Comput Aided Mol Des 13:533-545 (Pubitemid 29395566)
15. Egan WJ, Lauri G (2002) Prediction of intestinal permeability. Adv Drug Deliv Rev 54:273-289 (Pubitemid 34260954)
16. Franco LJ (1992) Diabetes in Brazil: a review of recent survey data. Ethn Dis 2:158-165
17. Irwin JJ, Lorber DM, McGovern SL, Wei B, Shoichet BK (2002) Computational nanoscience and nanotechnology. ISBN 0-9708275: 6-3
18. Jafri MA, Aslam M, Javed K, Singh S (2000) Effect of Punica granatum Linn. (flowers) on blood glucose level in normal and alloxan-induced diabetic rats. J Ethnopharmacol 70:309-314 (Pubitemid 30317369)
19. Jain AN (1996) Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities. J Comput Aided Mol Des 10:427-440 (Pubitemid 126712439)
20. Johnson DE, Wolfgang GH (2000) Predicting human safety: screening and computational approaches. Drug Discov Today 5:445-454
21. Kasuga M, Fujita-Yamaguchi Y, Blithe D, Kahn CR (1983) Tyrosine specific protein kinase activity is associated with insulin receptor. Proc Natl Acad Sci USA 80:2137-2141 (Pubitemid 13097150)
22. Kimura I (2006) Medical benefits of using natural compounds and their derivatives having multiple pharmacological actions. Yakugaku Zasshi 126(3):133-143
23. Koyuturk M, Ozsoy-Sacan O, Bolkent S, Yanardag R (2005) Effect of glurenorm on immunohistochemical changes in pancreatic beta cells of rats in experimental diabetes. Indian J Exp Biol 43:268-271 (Pubitemid 40359133)
24. Larsen TM, Toubro S, Astrup A (2003) PPAR gamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord 27(2): 147-161 (Pubitemid 36255796)
25. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3-26 (Pubitemid 33653411)
26. Muegge I (2006) PMF scoring revisited. J Med Chem 49:5895-5902 (Pubitemid 44484936)
27. Noor A, Gunasekaran S, Manickam AS, Vijayalakshmi MA (2008) Antidiabetic activity of Aloe vera and histology of organs in streptozotocin induced diabetic rats. Curr Sci 94:1070-1076 (Pubitemid 351705392)
28. Piedrola G, Novo E, Escober F, Garcia-Robles R (2001) White blood cell count and insulin resistance in patients with coronary artery disease. Annu Endocrinol (Paris) 62:7-10 (Pubitemid 32220392)
29. Rajalakshmi M, Eliza J, Cecilia Edel Priya, Lilly V, Daisy P (2009) Biochemical and Histopathological study of Cassia fistula bark extracts in STZ induced diabetic rats. Com6\D:\Journal-2009\23-Int J Biotechnol Res 2(1):35-40
30. Sawyer JS, Anderson BD, Beight DW, Campbell RM, Jones ML (2003) Synthesis and activity of new aryl- and heteroarylsubstituted pyrazole inhibitors of the transforming growth factorbeta type I receptor kinase domain. J Med Chem 46:3953-3956 (Pubitemid 37122441)
31. Schleyer PVR, MacKerell AD, Brooks B Jr, Brooks CL III, Nilsson L, Roux B, Won Y, Karplus M (1998) CHARMM: the energy function and its parameterization with an overview of the program. In: Schleyer PVR (ed) The encyclopedia of computational chemistry, vol 1. Wiley, Chichester, pp 271-277
32. Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N Engl J Med 341:248-257 (Pubitemid 29334524)
33. Shepherd PR, Withers DJ, Siddle K (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signaling. Biochem J 333: 471-490 (Pubitemid 28398511)
34. Singh J, Chuaqui CE, Boriack-Sjodin PA, Lee WC, Pontz T (2003) Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI). Bioorg Med Chem Lett 13:4355-4359 (Pubitemid 37490817)
35. Suryawanshi SA, Ghosh S (2001) Effect of Vinca rosea extracts in treatment of alloxan diabetes in male albino rats. Indian J Exp Biol 39:748-759 (Pubitemid 32736288)
36. Susnow RG, Dixon SL (2003) Use of robust classification techniques for the prediction of human cytochrome P450 2D6 inhibition. J Chem Inf Comput Sci 43:1308-1315
37. Taha C, Klip A (1999) The insulin signaling pathway. J Membr Biol 169:1-12 (Pubitemid 29211069)
38. Tanaka K, Nishizon OS, Makino N, Tamaru S, Terai O, Ikeda I (2008) Hypoglycemic activity of Eriobotrya japonica seeds in type 2 diabetic rats and mice. Biosci Biotechnol Biochem 72(3):686-693 (Pubitemid 351463683)
39. Trejo-Gonzalez A, Gabriel-Ortiz G, Puebla-Perez AM, Huizar-Contreras MD, Munguia-Mazariegos MR, Mella-Arreguin S, Calva E (1996) A purified extract from prickly pear cactus (Opuntia fuliginosa) controls experimentally induced diabetes in rats. J Ethnopharmacol 55:27-33 (Pubitemid 27051178)
40. Trinder P (1969) Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6:24-27
41. White MF (1998) The IRS signaling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182:3-11 (Pubitemid 28181643)
42. Whitton PD, Hems DA (1975) Glycogen synthesis in the perfused liver of streptozotocin-diabetic rats. Biochem J 150:153-165
43. World Health Organization.Fact sheet N-312.November 2008. Diabetes mellitus. http://www.who.int/mediacentre/factsheets/fs312/en/index.html
44. Yaryura-Tobias JA, Pinto A, Neziroglu F (2001) Anorexia nervosa, diabetes mellitus, brain atrophy, and fatty liver. Int J Etiol Disord 30:350-353 (Pubitemid 32843654)
45. Yu H et al (2007) The discovery of novel vascular endothelial growth factor receptor tyrosine kinases inhibitors: pharmacophore modeling, virtual screening and docking studies. Chem Biol Drug Des 69(3):204-211 (Pubitemid 46608455)